See more : Toga Limited (TOGL) Income Statement Analysis – Financial Results
Complete financial analysis of Advicenne S.A. (ADVIC.PA) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Advicenne S.A., a leading company in the Biotechnology industry within the Healthcare sector.
- HPL Electric & Power Limited (HPL.BO) Income Statement Analysis – Financial Results
- Synergetic Auto Performance Public Company Limited (ASAP.BK) Income Statement Analysis – Financial Results
- Restaurant Brands International Limited Partnership (RSTRF) Income Statement Analysis – Financial Results
- Salasar Techno Engineering Limited (SALASAR.BO) Income Statement Analysis – Financial Results
- Neutra Corp. (NTRR) Income Statement Analysis – Financial Results
Advicenne S.A. (ADVIC.PA)
About Advicenne S.A.
Advicenne S.A. develops therapeutics for the treatment of rare kidney diseases. Its lead product candidate is ADV7103 for the treatment of distal renal tubular acidosis in children and adults, as well as for the treatment of cystinuria, an inherited renal tubulopathy. The company also provides ADV6209, an oral liquid solution for children to reduce anxiety and to improve their immobility. Advicenne S.A. was founded in 2007 and is based in Paris, France.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 3.15M | 2.40M | 2.69M | 2.06M | 2.00M | 1.19M | 806.31K | 268.00K | 109.00K | 1.85M |
| Cost of Revenue | 1.73M | 1.12M | 973.00K | 886.00K | 12.85M | 8.46M | 4.45M | 99.00K | 44.00K | 2.28M |
| Gross Profit | 1.43M | 1.28M | 1.72M | 1.18M | -10.85M | -7.27M | -3.65M | 169.00K | 65.00K | -433.19K |
| Gross Profit Ratio | 45.26% | 53.40% | 63.82% | 57.03% | -542.73% | -610.76% | -452.39% | 63.06% | 59.63% | -23.44% |
| Research & Development | 3.75M | 7.08M | 8.96M | 8.15M | 7.64M | 7.13M | 4.96M | 80.00K | 80.00K | 0.00 |
| General & Administrative | 3.38M | 3.81M | 3.99M | 5.52M | 3.40M | 0.00 | 7.05M | 3.00M | 2.79M | 0.00 |
| Selling & Marketing | 1.08M | 1.07M | 1.57M | 3.83M | 4.01M | 0.00 | 1.50M | 671.00K | 0.00 | 0.00 |
| SG&A | 4.46M | 4.87M | 3.99M | 5.52M | 7.41M | 4.50M | 8.55M | 3.00M | 2.79M | 1.22M |
| Other Expenses | -332.00K | -611.00K | 1.21M | 1.65M | 3.80M | -1.58M | 1.80M | 255.00K | 638.00K | 0.00 |
| Operating Expenses | 7.88M | 11.34M | 14.16M | 15.31M | 3.80M | -1.58M | 1.80M | 3.34M | 3.51M | 2.05M |
| Cost & Expenses | 9.61M | 12.46M | 15.13M | 16.20M | 16.65M | 6.87M | 6.25M | 3.44M | 3.55M | 4.33M |
| Interest Income | 3.00K | 762.00K | 139.00K | 85.00K | 52.36K | 18.35K | 0.00 | 0.00 | 3.00K | 0.00 |
| Interest Expense | 577.00K | 1.37M | 148.00K | 553.00K | 6.18K | 10.42K | 69.16K | 406.00K | 164.00K | 0.00 |
| Depreciation & Amortization | 218.00K | 418.00K | 434.00K | 424.00K | 237.00K | 114.00K | 186.00K | 99.00K | 100.00K | 727.35K |
| EBITDA | -6.24M | -9.87M | -12.04M | -13.98M | -14.01M | -4.97M | -5.05M | -3.55M | -3.79M | -1.77M |
| EBITDA Ratio | -198.16% | -405.80% | -446.89% | -677.74% | -700.70% | -414.11% | -626.23% | -1,144.40% | -3,068.81% | -95.67% |
| Operating Income | -6.46M | -10.06M | -12.44M | -14.14M | -14.63M | -5.63M | -5.44M | -3.17M | -3.45M | -2.50M |
| Operating Income Ratio | -204.92% | -419.65% | -462.74% | -685.50% | -731.65% | -473.07% | -675.22% | -1,182.09% | -3,160.55% | -135.03% |
| Total Other Income/Expenses | -575.00K | -1.37M | 6.00K | -681.00K | 50.00K | 183.48K | -71.79K | -406.00K | -161.00K | 44.41K |
| Income Before Tax | -7.03M | -11.43M | -12.44M | -14.82M | -14.57M | -5.45M | -5.52M | -3.57M | -3.61M | -2.45M |
| Income Before Tax Ratio | -223.17% | -477.01% | -462.55% | -718.57% | -728.79% | -457.65% | -684.12% | -1,333.58% | -3,310.09% | -132.63% |
| Income Tax Expense | -1.00K | 37.00K | -11.00K | 29.00K | -850.68K | -820.71K | -861.42K | 406.00K | 163.00K | 460.32K |
| Net Income | -7.03M | -11.47M | -12.43M | -14.85M | -13.72M | -4.63M | -4.65M | -3.98M | -3.77M | -1.99M |
| Net Income Ratio | -223.14% | -478.56% | -462.14% | -719.98% | -686.24% | -388.68% | -577.29% | -1,485.07% | -3,459.63% | -107.72% |
| EPS | -0.67 | -1.13 | -1.32 | -1.69 | -1.61 | -0.58 | -0.78 | -0.62 | -0.59 | -0.31 |
| EPS Diluted | -0.67 | -1.13 | -1.32 | -1.69 | -1.61 | -0.58 | -0.77 | -0.62 | -0.59 | -0.25 |
| Weighted Avg Shares Out | 10.49M | 10.11M | 9.45M | 8.76M | 8.55M | 7.97M | 5.99M | 6.39M | 6.39M | 6.39M |
| Weighted Avg Shares Out (Dil) | 10.49M | 10.11M | 9.45M | 8.76M | 8.55M | 7.97M | 6.01M | 6.39M | 6.39M | 8.00M |
Source: https://incomestatements.info
Category: Stock Reports